Skip to content
CancerIndex

Ranking · Trend

Trial registration growth (year over year)

Relative change in the number of interventional studies first posted in the last 12 months versus the preceding 12 months, over the cancer and its descendants. Requires at least 20 studies in the prior window so small denominators do not produce spurious growth.

Computedci-trial-growth-v1unit: ratiohigher is first (neutral)All metrics

Top 15 by Trial registration growth (year over year)Malignant Breast Neoplasm0.23Malignant Prostate Neoplasm0.23Malignant Pancreatic Neoplasm0.22Malignant Central Nervous Sys…0.22Malignant Bladder Neoplasm0.18Malignant Gastric Neoplasm0.15Multiple Myeloma0.13Skin Carcinoma0.12Malignant Ovarian Neoplasm0.1Malignant Rectal Neoplasm0.1Malignant Lip and Oral Cavity…0.1Non-Hodgkin Lymphoma0.09Malignant Lung Neoplasm0.08Malignant Kidney Neoplasm0.07Malignant Liver Neoplasm0.05
RankΔCancerTrial registration growth (year over year) (ratio)PercentileConfidenceSourcesWhy #n?
1=Malignant Breast Neoplasm0.23100High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
673
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
547

ranking row 2569640

2=Malignant Prostate Neoplasm0.2395.7High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
317
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
258

ranking row 2569641

3=Malignant Pancreatic Neoplasm0.2291.3High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
217
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
178

ranking row 2569642

4=Malignant Central Nervous System Neoplasm0.2287High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
173
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
142

ranking row 2569643

5=Malignant Bladder Neoplasm0.1882.6Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
79
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
67

ranking row 2569644

6=Malignant Gastric Neoplasm0.1578.3High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
168
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
146

ranking row 2569645

7=Multiple Myeloma0.1373.9High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
170
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
150

ranking row 2569646

8=Skin Carcinoma0.1269.6Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
28
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
25

ranking row 2569647

9=Malignant Ovarian Neoplasm0.165.2High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
145
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
132

ranking row 2569648

10=Malignant Rectal Neoplasm0.160.9Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
101
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
92

ranking row 2569649

11=Malignant Lip and Oral Cavity Neoplasm0.156.5Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
45
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
41

ranking row 2569650

12=Non-Hodgkin Lymphoma0.0952.2High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
432
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
395

ranking row 2569651

13=Malignant Lung Neoplasm0.0847.8High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
669
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
619

ranking row 2569652

14=Malignant Kidney Neoplasm0.0743.5Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
101
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
94

ranking row 2569653

15=Malignant Liver Neoplasm0.0539.1High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
231
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
219

ranking row 2569654

16=Malignant Nasopharyngeal Neoplasm0.0534.8Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
61
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
58

ranking row 2569655

17=Malignant Thyroid Gland Neoplasm0.0530.4Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
43
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
41

ranking row 2569656

18=Malignant Esophageal Neoplasm0.0426.1High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
128
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
123

ranking row 2569657

19=Malignant Uterine Corpus Neoplasm0.0321.7Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
100
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
97

ranking row 2569658

20=Leukemia-0.0217.4High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
348
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
355

ranking row 2569659

21=Malignant Colon Neoplasm-0.0413Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
50
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
52

ranking row 2569660

22=Hodgkin Lymphoma-0.048.7Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
23
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
24

ranking row 2569661

23=Malignant Oropharyngeal Neoplasm-0.084.3Medium confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
24
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
26

ranking row 2569662

24=Malignant Cervical Neoplasm-0.130High confidenceclinicaltrials
inputs
asOf
2026-09-29
windows
new12m
to
2026-09-29
from
2025-09-29
prior12m
to
2025-09-29
from
2024-09-29
studyType
INTERVENTIONAL
aggregation
descendants
newTrials12m
103
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
minPriorTrials
20
newTrialsPrior12m
118

ranking row 2569663

Data updated 17 hours agoSource updated unknown24 eligible entities · inputs hash b2d3bb942d1267205c21d786